GSG. V. Sazanov

G. V. Sazanov

*This is an algorithmically generated author record based on publicly available information.

G. V. Sazanov has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Endovascular prevention of distal embolism in pathogenesis of no-reflow phenomenon in percutaneous coronary interventions in patients with ST-segment elevation acute coronary syndrome

    by G.V. Sazanov, Z.KH. Shugushev

    Pathogenesis of no/slow-reflow phenomenon following percutaneous coronary intervention (PCI) in patients with acute coronary syndrome and ST-segment elevation (STEMI) requires constant and in-depth study. It is known that no-reflow phenomenon is complex and can be triggered by combination of the following factors: 1) distal embolism of infarct-related coronary artery; 2) myocardial ischemic damage in appropriate coronary basin; 3) myocardial reperfusion injury; 4) genetic predisposition to microvascular damage. The risk of no-reflow or slow-reflow phenomenon is present at any stage of PCI. Most often, no-reflow phenomenon occurs due to distal embolism following balloon inflation during pre-dilatation or stent implantation. Distal embolism of infarct-related coronary artery due to fragmentation and migration of atherothrombotic conglomerate during PCI is sufficiently studied. Endovascular prevention of slow/no-reflow phenomenon took place in different years of development of endovascular surgery, and some ones are used now. At various times, surgeons used mesh-covered stents, manual and rheolytic thrombaspiration, protection by filter traps, proximal protection from distal embolism by temporary occlusion of infarct-related coronary artery. However, manual thromboaspiration currently occupies its niche, and indications for this procedure are limited. Intravenous administration of platelet glycoprotein IIB/IIIA receptor inhibitors is the most effective and common pharmacological method for the treatment and prevention of no-reflow or slow-reflow phenomenon. Some authors suppose that direct stenting of infarct-related coronary artery without pre-dilatation reduces the risk of distal embolism. That is why this strategy may be preferable for revascularization in STEMI patients to reduce the risk of microvascular embolization.


  • Open Access

    Treatment Outcomes in STEMI Patients With No/Slow-Reflow Phenomenon, Depending on Age

    by G. V. Sazanov, Z. Kh. Shugushev, О. С. Белоконь, S. V. Ermakov, A. V. Mukovnikova

    Objective: To assess the risks of no/slow-­reflow phenomena and treatment outcomes in patients with ST­-segment elevation myocardial infarction (STEMI) from different age groups.Materials and methods: We analyzed treatment outcomes of 535 STEMI patients who were divided into 4 groups based on their age: 33 patients younger than 44 years (group 1), 209 patients aged 45 to 59 years (group 2), 247 patients aged 60 to 74 years (group 3), and 46 patients aged 75 to 80 years (group 4).Results: Our study revealed that among the young people STEMI is more often found in men, whereas in the older population the number of women increases accounting for 37% (compare with 3% among the young patients). It was also shown that with age, statistically significantly more coronary stents (P = .009, Kruskal­Wallis test) are needed to repair an infarct-­related coronary artery lesion. The time required to perform a percutaneous coronary intervention was statistically significantly higher in the older adults than in the young patients (P = .022, Kruskal­-Wallis test).Conclusions: Our study found that the frequency of deaths was higher in STEMI patients from the older age groups (9.30% and 10.90%), whereas in the young patients, no deaths were registered during the 30­-day follow­up. In the middle­aged patients, mortality accounted for 3.3%. The reported differences were statistically significant (P = .016, Pearson’s χ2). The analysis of overall survival based on the age group revealed statistically significant differences (likelihood ratio test, P = .006).

  • Open Access

    Dilation of the Infarct-Related Coronary Artery to Reduce the Incidence of the No-Reflow Phenomenon in STEMI Patients

    by G. V. Sazanov, Z. Kh. Shugushev, О. С. Белоконь, S. V. Ermakov, A. A. Khripunova

       Background: The pathogenesis of slow/no-reflow phenomena is a critical socio-medical problem due to high mortality and work disability rates in patients with ST-segment elevation myocardial infarction (STEMI). Slow/no-reflow phenomena are multifactorial involving 4 key elements: 1) distal embolization of the coronary bed of the infarct-related coronary artery; 2) ischemic damage to the myocardium; 3) reperfusion injury of the heart muscle; 4) individual (genetic) susceptibility of the microcirculation to injury.   Objective: To analyze the outcomes of percutaneous coronary interventions (PCI) in patients with STEMI and TIMI 0 blood flow of an infarct-related coronary artery based on the strategy to restore antegrade blood flow (balloon predilation or dilation of an infarctrelated artery).   Materials and methods: We analyzed treatment outcomes of 209 patients with STEMI and TIMI 0 blood flow. The patients were grouped based on the PCI strategy: group 1 included 147 patients who underwent balloon angioplasty to restore antegrade blood flow, and group 2 included 62 patients who underwent dilation of an infarct-related coronary artery.   Results: Our study found that direct stenting in STEMI patients was associated with statistically significantly lower risk of slow/noreflow phenomena (P = 0.001, Pearson’s χ2) and, as a result, better functional outcomes of treatment (chronic heart failure grade classified according to Strazhesko-Vasilenko and by left ventricular ejection fraction) that were also statistically significant (P = 0.001, Pearson’s χ2).   Conclusions: Our study demonstrated that the risk of slow/no-reflow phenomena in patients with TIMI 0 blood flow of an infarctrelated coronary artery was statistically significantly lower (P = .001, Pearson’s χ2) in the group of patients who underwent dilation of an infarct-related coronary artery to restore antegrade blood flow. Functional outcomes (chronic heart failure grade and overall survival) were also better in this group of patients (P = .001, Pearson’s Chi-square). Moreover, dilation of an infarct-related coronary artery was associated with preserved left ventricular ejection fraction compared with the group of patients who underwent balloon angioplasty to restore antegrade blood flow (P < 0.001, Pearson’s χ2).